ANTIFUNGAL STEWARDSHIP:  MITIGATING INAPPROPRIATE PRESCRIPTIONS IN VULVOVAGINAL CANDIDIASIS IN TERTIARY CARE HOSPITAL, CENTRAL INDIA

NARLAPATI VIGNAN; VIKALP TIWARI; AVINA KHARAT; RUCHI KUMARI

doi:10.22159/ijpps.2024v16i4.50496

Authors

NARLAPATI VIGNAN Department of Pharmacology, Mahatma Gandhi Memorial Medical College, A. B. Road, Indore, Madhya Pradesh, India
VIKALP TIWARI Department of Pharmacology, Mahatma Gandhi Memorial Medical College, A. B. Road, Indore, Madhya Pradesh, India
AVINA KHARAT Department of Pharmacology, Mahatma Gandhi Memorial Medical College, A. B. Road, Indore, Madhya Pradesh, India
RUCHI KUMARI Department of Pharmacology, Mahatma Gandhi Memorial Medical College, A. B. Road, Indore, Madhya Pradesh, India

DOI:

https://doi.org/10.22159/ijpps.2024v16i4.50496

Keywords:

Vaginal candidiasis, Antifungal stewardship, Inappropriate prescriptions, Tertiary care hospital, Ambispective study, Educational interventions

Abstract

This study aims to reduce the inappropriate prescriptions of antifungal medications for vulvovaginitis candidiasis in a tertiary care hospital in central India. An ambispective, observational study was conducted in the Department of Pharmacology of MGM Medical College and Maharaja Yashwantrao Hospital in Indore, MP, over three months (i.e.,12 w from August to October 2023). The study encompassed a retrospective analysis of prescriptions for vaginal candidiasis over a period of five weeks in August-September 2023, followed by a prospective analysis over the subsequent five weeks of September-October 2023post-implementation of interactive training sessions, discussions, and antifungal guidelines for two weeks. From a total of 130 randomly selected prescriptions, 69 prescriptions were perused retrospectively, while 61 prescriptions received prospective analysis. The post-implemented audit showed a marked reduction in antifungal prescriptions with a difference of 12.4%. An increase in the documentation of examination findings was also observed, from 46.7% to 69.7%. This implementation successfully mitigated inappropriate prescriptions of antifungals, with sustained reductions demonstrated over the 3 mo of the study period, emphasizing the effectiveness of educational interventions.

Downloads

Download data is not yet available.

References

Sathi FA, Alam MM, Paul SK, Nasrin SA, Ahmed S, Haque N. Species identification and antifungal susceptibility pattern of candida isolates in patients with vulvovaginitis from Mymensingh, Bangladesh. Mymensingh Med J. 2023 Jul;32(3):638-43. PMID 37391952.

Mohammed BL, Bander KI, Hamad TA. Prevalence of vaginal candidiasis among women and diagnosis of Candida species from vaginal infection in Kirkuk city. Magallat Tikrit. 2023;20(4):5-15. doi: 10.25130/tjps.v20i4.1206.

Bairagi GR, Patel VP. Formulation and development of curcumin based emulgel in treatment and recurrence of vaginal candidiasis. Int J Curr Pharm Res. 2021;13(5):89-99. doi: 10.22159/ijcpr.2021v13i5.1900.

Learn more about vaginal candidiasis (vaginal yeast infections). Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/fungal/diseases/candidiasis/genital/index.html. [Last accessed on 02 Mar 2024]

Denning DW, Kneale M, Sobel JD, Rautemaa Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018 Nov;18(11):e339-47. doi: 10.1016/S1473-3099(18)30103-8, PMID 30078662.

Jacob L, John M, Kalder M, Kostev K. Prevalence of vulvovaginal candidiasis in gynecological practices in germany: a retrospective study of 954,186 patients. Curr Med Mycol. 2018 Mar;4(1):6-11. doi: 10.18502/cmm.4.1.27, PMID 30186987, PMCID PMC6101156.

Seth S, Gandhi AB, Purandare A, Athota K, Kumar PG, Tandon S. Vulvovaginal candidiasis: epidemiology, treatment and prevention strategies. Indian J Obstet Gynecol Res. 2022 Aug 15;9(3). doi: 10.18231/j.ijogr.2022.063.

Kumar S, Goyal R, Kumar A. Determination of vulvovaginal candidiasis in Tertiary Care Hospital. Asian J Pharm Clin Res 2022;15(8):201-4. doi: 10.22159/ajpcr.2022.v15i8.44302.

Raytthatha N, Vyas J. Development of bigels containing antifungal agent for vaginal infection. Int J Pharm Pharm Sci. 2022;14(10):38-42. doi: 10.22159/ijpps.2022v14i10.45134.

Vulvovaginal candidiasis-STI treatment Guidelines. Available from: https://www.cdc.gov/std/treatment-guidelines/candidiasis.html. [Last accessed on 02 Mar 2024]

Fungi Antimicrobial-Resistant. Fungal diseases. Centers for Disease Control and Prevention (US). Available from: https://www.cdc.gov/fungal/antifungal-resistance.html. [Last accessed on 02 Mar 2024]

Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis. 2008 Jan 1;46(1):120-8. doi: 10.1086/524071, PMID 18171227.

Dennerstein GJ, Ellis DH, Reed CS, Bennett CM. Pathogenicity of non-albicans yeasts in the vagina. J Low Genit Tract Dis. 2011 Jan 1;15(1):33-6. doi: 10.1097/lgtLGT.0b013e3181d94f39, PMID 21192174.

Friese K, Neumann G, Siebert J. Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Arch Gynecol Obstet. 2003 Aug 1;268(3):194-7. doi: 10.1007/s00404-002-0368-6, PMID 12942250.

Kothari N, Hawser S, Olari S, Sartori S, Mathur T. P476 monitoring antifungal resistance in a global collection of candida spp. surveillance isolates, including C. auris-analysis of resistance in antifungals (ARIA) 2020 study. Med Mycol. 2022 Sep 1;60Suppl 1:476. doi: 10.1093/mmy/myac072.P476.

Johnson MD, Lewis RE, Dodds Ashley ESD, Ostrosky Zeichner L, Zaoutis T, Thompson GR. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020 Aug 5;222Suppl 3:S175-98. doi: 10.1093/infdis/jiaa394, PMID 32756879.

Ray, Das, Panda. Antifungal stewardship: what we need to know. Indian Journal of Dermatology, Venereology and Leprology; 2023. Available from: https://ijdvl.com/view-pdf/?article=d5bfb2cd87a23dcc9a0f750988ee2d013Ugna2Q0OQrpFA==. [Last accessed on 16 Nov 2023]

Capoor MR, Subudhi CPK, Collier A, Bal AM. Antifungal stewardship with an emphasis on candidaemia. J Glob Antimicrob Resist. 2019 Dec 1;19:262-8. doi: 10.1016/j.jgar.2019.05.030, PMID 31195147.

Sofjan AK, Musgrove RJ, Garey KW. Impact of new diagnostic approaches for invasive candidiasis on antifungal stewardship. Curr Fungal Infect Rep. 2016;10(2):68-77. doi: 10.1007/S12281-016-0257-2.

Gamarra F, Nucci M, Nouer SA. Evaluation of a stewardship program of antifungal use at a Brazilian tertiary care hospital. Braz J Infect Dis. 2022 Jan 1;26(1):102333. doi: 10.1016/j.bjid.2022.102333, PMID 35180447.

Al Balushi KA, Alzaabi MA, Alghafri F. Prescribing pattern of antifungal medications at a tertiary care hospital in Oman. J Clin Diagn Res. 2016 Jan 1;10(12):FC27-30. doi: 10.7860/jcdrJCDR/2016/23591.9005, PMID 28208876.

Sangwan R, Neels AJ, Gwini SM, Saha SK, Athan E. Is education alone enough to sustain improvements of antimicrobial stewardship in general practice in Australia? Results of an intervention follow-up study. Antibiotics (Basel). 2023 Mar 16;12(3):594. doi: 10.3390/antibiotics12030594, PMID 36978461, PMCID PMC10044534.